0001595971-17-000002.txt : 20170224 0001595971-17-000002.hdr.sgml : 20170224 20170224151201 ACCESSION NUMBER: 0001595971-17-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170224 DATE AS OF CHANGE: 20170224 EFFECTIVENESS DATE: 20170224 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Agilis Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001595971 IRS NUMBER: 463936833 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-281302 FILM NUMBER: 17636765 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (214)706-4340 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Agilis Biotherapeutics, LLC DATE OF NAME CHANGE: 20140106 D 1 primary_doc.xml X0707 D LIVE 0001595971 Agilis Biotherapeutics, Inc. 245 FIRST STREET SUITE 1800 CAMBRIDGE MA MASSACHUSETTS 02142 (617)444-8706 DELAWARE Agilis Biotherapeutics, LLC Corporation true 2013 G. Houston Hall 245 FIRST STREET Suite 1800 Cambridge MA MASSACHUSETTS 02142 Director Director Alexander M. Seaver 245 FIRST STREET Suite 1800 Cambridge MA MASSACHUSETTS 02142 Director Adrian Z. Stecyk 245 FIRST STREET Suite 1800 Cambridge MA MASSACHUSETTS 02142 Director Mark J. Pykett 245 FIRST STREET Suite 1800 Cambridge MA MASSACHUSETTS 02142 Executive Officer Director President and Chief Executive Officer Ian Ratcliffe 245 FIRST STREET Suite 1800 Cambridge MA MASSACHUSETTS 02142 Director Robert Hardie 245 FIRST STREET Suite 1800 Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b false 2017-02-15 false true true false 0 23335392 12668727 10666665 false 19 0 0 0 false Agilis Biotherapeutics, Inc. Mark Pykett Mark Pykett President and Chief Executive Officer of the Issuer 2017-02-24